EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“Today at the European Medicines Agency Cancer Medicines Forum (CMF), EORTC CEO Denis Lacombe highlights collaborative models between industry and academia to drive treatment optimization post-approval in clinical cancer research. Independent research partnerships are essential to ensure real-world evidence and better patient outcomes.”

More posts featuring EORTC on OncoDaily.